- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03074383
Improvement of Care for Outpatients With Type 2 Diabetes Through Self-Care Multidisciplinary Workshop for Diabetes
Improvement of Care for Outpatients With Type 2 Diabetes at the Porto Alegre Clinic Hospital Through Self-Care Multidisciplinary Workshop for Diabetes: a Randomized Controlled Trial
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Ninety-six patients with type 2 diabetes from our Diabetes Outpatient Clinic will be randomly assigned to maintain standard treatment or participate in the Self-Care Multidisciplinary Workshop for Diabetes. The workshop consists of 15-minute individual meetings with each professional of a multidisciplinary team (nurse, pharmacist, nutritionist, physical educator and social worker) in which education and self-care topics will be approached aiming at the formation of knowledge and skills necessary for patient self-care. The workshop will be offered in 3 different modules with 2 to 4 weeks difference between them.
Patients will be followed for 12 months. The variation of glycated hemoglobin as well as aspects associated with self-care, adherence and quality of life will be evaluated at the study entry, 6 and 12 months later.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Rio Grande Do Sul
-
Porto Alegre, Rio Grande Do Sul, Brasil, 90035-903
- Hospital de Clinicas de Porto Alegre
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patients with previous diagnosis of type 2 diabetes, HbA1c greater than 7.5% and age greater than 18 years
Exclusion Criteria:
- Types of diabetes other than type 2 diabetes; neurological, psychiatric or cognitive impairment that prevents proper understanding and participation in the workshop
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Workshop
Self-Care Multidisciplinary Workshop for Diabetes consist in individual meetings with a multidisciplinary team (nurse, pharmacist, nutritionist, physical educator, physiotherapist and social worker) in which education and self-care topics will be approached.
The workshop will be offered in 3 different modules with 2-4 weeks difference between them.
|
A 15-minute Individual meetings with each professional (nurse, pharmacist, nutritionist, physical educator, physiotherapist and social worker) of the multidisciplinary team in which diabetes education and self-care topics will be approached.
Andre navn:
|
Aktiv komparator: Usual Care
Usual care at outpatient Diabetes clinic AND 3 brief meetings with research team to receive printed educational material.
|
Usual care at outpatient Diabetes clinic AND 3 brief meetings with research team to receive printed educational material.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change in glycated hemoglobin from baseline at 12 months
Tidsramme: 12 months
|
Variation of glycated hemoglobin
|
12 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change in glycated hemoglobin from baseline at 6 months
Tidsramme: 6 months
|
Variation of glycated hemoglobin
|
6 months
|
Variation of Diabetes Quality of Life Questionnaire from baseline at 6 months
Tidsramme: 6 months
|
Diabetes Quality of Life Questionnaire
|
6 months
|
Variation of Diabetes Quality of Life Questionnaire from baseline at 12 months
Tidsramme: 12 months
|
Diabetes Quality of Life Questionnaire
|
12 months
|
Glycated hemoglobin equal or less than 8,0
Tidsramme: 12 months
|
Number of patients reaching glycated hemoglobin equal or less than 8,0
|
12 months
|
Glycated hemoglobin equal or less than 7,5
Tidsramme: 12 months
|
Number of patients reaching glycated hemoglobin equal or less than 7,5
|
12 months
|
Variation of Summary of Diabetes Self-Care Activities Questionnaire (SDSCA) from baseline at 6 months
Tidsramme: 6 months
|
Change in SDSCA score 6 months after baseline
|
6 months
|
Variation of Summary of Diabetes Self-Care Activities Questionnaire (SDSCA) from baseline at 12 months
Tidsramme: 12 months
|
Change in SDSCA score 12 months after baseline
|
12 months
|
Samarbeidspartnere og etterforskere
Etterforskere
- Studieleder: Beatriz DAgord Schaan, PhD, Hospital de Clinicas de Porto Alegre
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 16-0646
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Type 2 diabetes mellitus
-
US Department of Veterans AffairsAmerican Diabetes AssociationFullførtType 2 diabetes mellitusForente stater
-
Dexa Medica GroupFullførtType-2 diabetes mellitusIndonesia
-
University Hospital Inselspital, BerneFullført
-
India Diabetes Research Foundation & Dr. A. Ramachandran...Fullført
-
Shanghai Zhongshan HospitalFullført
-
Daewoong Pharmaceutical Co. LTD.FullførtT2DM (type 2 diabetes mellitus)Korea, Republikken
-
Daewoong Pharmaceutical Co. LTD.FullførtT2DM (type 2 diabetes mellitus)Korea, Republikken
-
Novartis PharmaceuticalsFullførtType 2 diabetes mellitus (T2DM)Forente stater
-
Merck Sharp & Dohme LLCFullførtType 2 diabetes mellitus (T2DM)
-
AstraZenecaBristol-Myers SquibbFullført
Kliniske studier på Workshop
-
University of SurreyFullført
-
Shiraz University of Medical SciencesShiraz education development centerFullført
-
University of California, San FranciscoUniversity of California, Berkeley; National Institute of Environmental... og andre samarbeidspartnereRekrutteringRisikoreduksjon | Bare barn | MiljøeksponeringForente stater
-
LiquidGoldConceptJohns Hopkins University; University of Michigan; Michigan State UniversityFullførtAmming | PasientsimuleringForente stater
-
McMaster UniversitySocial Sciences and Humanities Research Council of CanadaFullførtSosial isoleringCanada
-
University of Erlangen-Nürnberg Medical SchoolGerman Federal Ministry of Education and Research; University of Erlangen-NürnbergUkjentRyggsmerte | KommunikasjonTyskland
-
University of HoustonFullførtPsykiske lidelser | Traume | Posttraumatisk stresslidelse | Tankefullhet | BrannmennForente stater
-
University of AlbertaAlberta Innovates Health SolutionsFullført
-
Tel-Aviv Sourasky Medical CenterDuke UniversityUkjentFortvilelse blant kreftpasienter og onkologerForente stater, Israel
-
Fundació Institut de Recerca de l'Hospital de la...FullførtAldersrelaterte hukommelsesforstyrrelser | MinnetapSpania